Cargando…
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells
SIMPLE SUMMARY: We used fresh or thawed Umbilical Cord Blood (UCB) to produce CAR-T cells directed against CD123, and we compared their functionality to Peripheral Blood (PB) CAR-T cells. T cells expressing CD123 CAR, derived from UCB, was exhibited through a high transduction rate, activation statu...
Autores principales: | Caël, Blandine, Galaine, Jeanne, Bardey, Isabelle, Marton, Chrystel, Fredon, Maxime, Biichle, Sabeha, Poussard, Margaux, Godet, Yann, Angelot-Delettre, Fanny, Barisien, Christophe, Bésiers, Christophe, Adotevi, Olivier, Pouthier, Fabienne, Garnache-Ottou, Francine, Bôle-Richard, Elodie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264759/ https://www.ncbi.nlm.nih.gov/pubmed/35804941 http://dx.doi.org/10.3390/cancers14133168 |
Ejemplares similares
-
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR‐T cell cytotoxicity
por: Poussard, Margaux, et al.
Publicado: (2020) -
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
por: Philippe, Laure, et al.
Publicado: (2017) -
Conventional Therapeutics in BPDCN Patients—Do They Still Have a Place in the Era of Targeted Therapies?
por: Poussard, Margaux, et al.
Publicado: (2022) -
Lymphoblastic T Cells and Mature NK Cells With the Same TCRγ Rearrangement: A Common Origin?
por: Roggy, Anne, et al.
Publicado: (2021) -
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
por: Galaine, Jeanne, et al.
Publicado: (2015)